Follicle Stimulating Hormone
/api/v1/drug/follicle-stimulating-hormoneMechanism of action
Sourced from openFDAMechanism-of-action classes: Hormone Receptor Agonists; Hormone Receptor Modulators.
Indications
Sourced from openFDA- HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.
Dosage & administration
Sourced from openFDADIRECTIONS: 1-10 drops under the tongue, 3 times a day or as directed by your health professional. Consult a physician for use in children under 12 years of age.
Warnings & precautions
Sourced from openFDAKeep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding, ask a healthcare professional before use. Tamper seal: sealed for your protection. Do not use if seal is broken or missing.
FAERS reports
- 1Chills150%
- 2Dizziness150%
- 3Fatigue150%
- 4Headache150%
- 5Hyperhidrosis150%
- 6Incorrect Dose Administered150%
- 7Nausea150%
- 8Pyrexia150%
- 9Wrong Technique In Device Usage Process150%
Literature
Recent PubMed references pinned to Follicle Stimulating Hormone as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.
- Beneficial Effect of Follicle-Stimulating Hormone Priming on OPU-IVF in Prepubertal Calves of Japanese Black Cattle (Wagyu).Reproduction in domestic animals = Zuchthygiene · 2026 · Liu Z, Zhao H, Chen X, et al.PMID 42249736DOI 10.1111/rda.70242
- Functional data analysis of FSH and inhibin B levels in four ovulatory cycles shows a changing oscillatory interaction during the follicular phase.Frontiers in endocrinology · 2026 · Usala SJ, Trindade AA, Vineyard DD, et al.PMID 42222099DOI 10.3389/fendo.2026.1741869
- Effect of recombinant human follicle-stimulating hormone or equine chorionic gonadotropin on the ovarian response in guinea pig.Veterinary research communications · 2026 · Cedano-Castro JI, Saavedra MB, Zavaleta PM, et al.PMID 42213185DOI 10.1007/s11259-026-11306-0
- High serum FSH levels on day 7 of stimulation are negatively associated with oocyte retrieval in GnRH antagonist protocols: real-world evidence from 9,969 IVF cycles in China.Frontiers in endocrinology · 2026 · Luo X, Ye H, Pei L, et al.PMID 42165020DOI 10.3389/fendo.2026.1757107
- Single-chain human Follicle-stimulating hormone promotes ovarian and testicular growth and improves pregnancy performance in mice.PloS one · 2026 · Nguyen TT, Nong VH, Nguyen TMD, et al.PMID 42133675DOI 10.1371/journal.pone.0349398
- Luteinizing hormone activity in ovarian stimulation: comparative efficacy and safety of gonadotropins versus recombinant follicle-stimulating hormone-a systematic review and meta-analysis.Frontiers in endocrinology · 2026 · Espinós JJ, Checa MA, Villegas-Arbelaez E, et al.PMID 42100203DOI 10.3389/fendo.2026.1792900
- Macromolecular interactions of recombinant human follicle stimulating hormone (r-hFSH) with piscine FSH receptors enhance reproductive development in Clarias magur: in silico data corroborated by an in vivo study.Molecular biology reports · 2026 · Akamad K, Chanu TI, Sukhdhane K, et al.PMID 42053706DOI 10.1007/s11033-026-11870-3
- The DIVINE dose-selection model in daily ART practice: effects on live birth rate and safety.Reproductive biomedicine online · 2026 · Schouten NE, van Tilborg TC, Cianci D, et al.PMID 42033979DOI 10.1016/j.rbmo.2026.105496
Clinical trials
The 10 most recently updated of 474 ClinicalTrials.gov registrations naming Follicle Stimulating Hormone as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)Recruiting · Phase 3 · Interventional · 266 enrolled · Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07340827updated 2026-06-11
- Assessing the Effects of Hormones on Noninvasive Transcranial StimulationNot yet recruiting · Interventional · 25 enrolled · Carnegie Mellon UniversityNCT07635017updated 2026-06-09
- Pharmacokinetics of FSH and hCG Following Multiple Dose of Gonadotropins-IBSA.Completed · Phase 1 · Interventional · 28 enrolled · IBSA Institut Biochimique SANCT06659692updated 2026-06-05
- Exogenous Progesterone as Ovulation TriggerNot yet recruiting · Phase 4 · Interventional · 10 enrolled · Instituto Valenciano de Infertilidade de LisboaNCT07466199updated 2026-06-04
- Testing the Addition of a New Anti-Cancer Drug, Niraparib, to the Usual Treatment (Hormone and Radiation Therapy) for Prostate Cancer With a High Chance of RecurringCompleted · Phase 1 · Phase 2 · Interventional · 22 enrolled · NRG OncologyNCT04037254updated 2026-05-20
- Measurement of Urinary Hormones in Patients With Abnormal Uterine Bleeding to Study Uterine Cancer ProgressionNot yet recruiting · Observational · 50 enrolled · University of British ColumbiaNCT07581288updated 2026-05-12
- Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist ProtocolNot yet recruiting · Observational · 252 enrolled · ART Fertility Clinics LLCNCT06879002updated 2026-05-07
- Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility ProblemsEnrolling by invitation · Interventional · 50 enrolled · Universitair Ziekenhuis BrusselNCT04202094updated 2026-05-06
- Using a Fixed Dosage of Follitropin Delta for Ovarian Stimulation for Intrauterine Insemination: Rekovelle for Intrauterine Successful Experience (RISE)Recruiting · Phase 2 · Interventional · 80 enrolled · Centre Hospitalier Intercommunal CreteilNCT07153367updated 2026-04-08
- Brain Irradiation for Childhood Cancer - Endocrine Monitoring During the First YearsRecruiting · Interventional · 230 enrolled · University Hospital, AngersNCT06618703updated 2026-04-06
Frequently asked questions
- How does Follicle Stimulating Hormone work?
- Mechanism-of-action classes: Hormone Receptor Agonists; Hormone Receptor Modulators.
- What is Follicle Stimulating Hormone used for?
- According to FDA labeling, Follicle Stimulating Hormone carries indications including: HOMEOPATHIC INDICATIONS: Temporary relief of symptoms related to hormone imbalances of insufficiencies in men and women, including low energy, inability to handle stress, trouble focusing, changes in mood, infertility, irregular menstrual cycles (females), and lack of libido.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
- What class of drug is Follicle Stimulating Hormone?
- Follicle Stimulating Hormone is classified as Gonadotropin, Hormone Receptor Agonists, Hormone Receptor Modulators, Increase Spermatogenesis, Increased Follicle Stimulating Hormone Secretion, Stimulate Ovarian Follicular Phase, Thyroid Gland Activity Alteration.
- What are the brand names for Follicle Stimulating Hormone?
- Follicle Stimulating Hormone is marketed under brand names including Menopur, Pluset.
follicle-stimulating-hormone is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.